Legal & General Group PLC Uro Gen Pharma Ltd. Transaction History

Legal & General Group PLC

$423 Billion
Q1 2024

A detailed history of Legal & General Group PLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Legal & General Group PLC holds 2,785 shares of URGN stock, worth $44,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,785

Previous 2,785 -0.0%

Holding current value

$44,225

Previous $41,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$13.81 - $19.33 $1,146 - $1,604	-83 Reduced 2.89%	2,785 $41,000
Q4 2023 Feb 15, 2024	BUY	$10.87 - $15.93 $8,022 - $11,756	738 Added 34.65%	2,868 $43,000
Q3 2023 Nov 14, 2023	SELL	$8.84 - $22.64 $1,547 - $3,962	-175 Reduced 7.59%	2,130 $29,000
Q2 2023 Aug 14, 2023	BUY	$8.75 - $14.29 $20,168 - $32,938	2,305 New	2,305 $23,000
Q2 2022 Aug 22, 2022	SELL	$5.12 - $8.74 $50,467 - $86,150	-9,857 Closed	0 $0

Q1 2022 May 16, 2022	BUY	$5.92 - $9.73 $41,842 - $68,771	7,068 Added 253.42%	9,857 $86,000
Q1 2021 May 17, 2021	SELL	$17.99 - $26.96 $7,825 - $11,727	-435 Reduced 13.49%	2,789 $54,000
Q3 2020 Nov 13, 2020	SELL	$18.81 - $26.42 $15,104 - $21,215	-803 Reduced 19.94%	3,224 $62,000
Q2 2020 Aug 14, 2020	SELL	$16.5 - $29.7 $874 - $1,574	-53 Reduced 1.3%	4,027 $105,000
Q1 2020 May 14, 2020	SELL	$13.68 - $34.6 $12,216 - $30,897	-893 Reduced 17.96%	4,080 $73,000
Q4 2019 Feb 13, 2020	BUY	$21.11 - $34.86 $15,748 - $26,005	746 Added 17.65%	4,973 $166,000
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $108,697 - $133,921	3,319 Added 365.53%	4,227 $140,000
Q1 2019 May 15, 2019	BUY	$35.47 - $54.55 $19,011 - $29,238	536 Added 144.09%	908 $33,000
Q2 2018 Aug 10, 2018	BUY	$48.35 - $65.33 $17,986 - $24,302	372 New	372 $18,000

Others Institutions Holding URGN

# of Institutions

113

Shares Held

24M

Call Options Held

46.9K

Put Options Held

44.3K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $361M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Uro Gen Pharma Ltd. Transaction History